Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support

In this Q&A, MaxCyte’s Sarah Meeks, Ph.D., discusses the potential of electroporation in driving the future of the cell engineering field and the role MaxCyte is looking to play in that evolution.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: